Gregory Alan Korbel - 03 Jun 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Signature
/s/ Scott M. Coiante, attorney-in-fact
Issuer symbol
APRE
Transactions as of
03 Jun 2022
Net transactions value
-$6,754
Form type
4
Filing time
07 Jun 2022, 17:01:23 UTC
Previous filing
14 Mar 2022
Next filing
01 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability $6,754 -8,390 -28% $0.8050* 21,462 03 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 24,334 restricted stock units